CXCL8 Regulation and Function in HIV Infections and Potential Treatment Strategies by Per-Erik Olsson et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






CXCL8 Regulation and Function in HIV 
Infections and Potential Treatment Strategies 
Per-Erik Olsson, Hazem Khalaf and Jana Jass 
Örebro Life Science Center, School of Science and Technology, Örebro University 
Sweden 
1. Introduction 
Interleukin-8 (CXCL8) is a chemokine that was originally identified as a key factor in 
neutrophil recruitment and activation. Numerous cell types produce CXCL8, including 
immune cells, mucosal epithelial cells, endothelial cells and smooth muscle cells (Garcia-
Vicuna et al., 2004). CXCL8 is one of the important inflammatory mediators responsible for 
the recruitment of neutrophils and T-cells to the site of infection, therefore it is an attractive 
target for therapy against diseases that affect immune cells such as HIV. HIV directly targets 
the host’s immune system and thus reduces the ability of the innate and adaptive immune 
system to fight disease. As a chemokine, CXCL8 is a potential target for controling HIV 
infection by reducing the migration of T-cells to the site of infection. It is therefore necessary 
to identify the signaling pathways involved in CXCL8 regulation in order to develop viable 
CXCL8 based treatment strategies. In line with this, we have recent shown that CXCL8 
activation in Jurkat T-cells is not primarily under the control of NFB, but that the AP-1 
signaling pathway appears to be central for the regulation of CXCL8 (Khalaf et al., 2010).  
An understanding of the regulation and function of cytokines and chemokines, while 
complex, remains important for the development of new strategies in the development of 
HIV treatments. It is interesting to note that several lactobacilli strains are able to modulate 
CXCL8 expression and release (Anukam et al., 2009; Zhang et al., 2005). Disturbance of the 
lactobacilli flora in the vaginal tract has been shown to increase the risk of infections and 
acquisition of HIV type 1 (Taha et al., 1998). Several studies have shown that treatment with 
certain Lactobacillus species and strains have positive effects on women with HIV infections 
and have been successful in trials to counteract vaginal infections (Hummelen et al., 2010; 
Spear et al., 2007).  
In the present chapter we give a background to CXCL8 regulation and function as well as its 
involvement in HIV etiology. We also provide an overview of the available information on 
the possible uses of Lactobacillus species in treatment of infections with special emphasis on 
HIV. In addition, the effects obtained by using lactobacilli treatment together with 
expression of adhesion inhibitors will be discussed. The aim is to give the reader an 
overview of the role of CXCL8 in HIV infections and combine this with information on how 
lactobacilli treatment influences the chemokine levels and evaluate these systems potential 
in the treatment of HIV patients. 
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1.1 Inflammatory responses 
Pro-inflammatory cytokines, such as TNF, IL-1 and IL-6, as well as the chemokine CXCL8 
promote inflammation, whereas anti-inflammatory cytokines, including IL-4, IL-10 and IL-
13, suppress the activity of pro-inflammatory cytokines (Dinarello, 2000). Gene-expression 
and release of cytokines, such as TNF, IL-1 and IL-6, and cell adhesion molecules, including 
ICAM-1, P selectin, and E selectin, are indicators of induced inflammatory responses 
(Pearson et al., 2003). NF-B has been proposed as the main transcriptional regulator of 
cytokine expression, adhesion factors and anti-apoptotic factors (McKay & Cidlowski, 1999). 
It has been suggested that inflammatory cytokines, such as TNF, are involved in the 
induction of reactive oxygen intermediates (O2-) that cause DNA damage (Shoji et al., 1995). 
Recent observations have shown that elevated levels of IL-6 and C-reactive protein are 
associated with the development of atherosclerosis and type II diabetes (Libby et al., 2002). 
Elevated cytokine levels are also associated with cellular senescence and may be involved in 
telomere shortening and continuous cell divisions (Itahana et al., 2001).  
1.2 T-cell derived inflammatory responses 
Optimal T-cell activation is achieved following antigen binding to the T-cell receptor (TCR), 
together with co-stimulatory signals followed by cytokine expression (Gonzalo et al., 2001). 
T-cells produce a broad range of pro- and anti-inflammatory cytokines, including IL-2, IL-6, 
IL-10 and TNF, in response to infections (Opal & DePalo, 2000). IL-10 is another important 
anti-inflammatory cytokine expressed by activated T-cells, providing control of intestinal 
inflammatory responses, but is also important for normal T-cell function (Asseman et al., 
1999). Chemokine expression (CXCL8) by CD8+ T-cells is crucial in immune responses by 
inducing cytokines, such as TNF and IFN-γ by CD4+ cells, and antibody secretion by B-cells 
(Kim et al., 1998). Recent findings provide evidence indicating expression of several types of 
Toll-like receptors (TLRs), including TLR4, on T-cells (Caramalho et al., 2003). These results 
demonstrate a specific role of T-cells in the induction of inflammatory responses by direct 
recognition of antigens, independent of antigen-presenting cells.  
1.3 Epithelial cell derived inflammatory responses 
Wounds, chemical irritation or infection may cause inflammation of the epithelial surface. 
Acute inflammation induces expression of pro-inflammatory cytokines and chemokines that 
attract immune cells, such as neutrophils, followed by the production of anti-inflammatory 
cytokines thereby initiating the healing process (Philip et al., 2004). The balance between 
pro- and anti-inflammatory cytokines determines the severity of an infection. However, 
prolonged inflammatory responses are prevented by the expression of IL-1ra, 
glucocorticoids and IL-10, which also improves cell survival (Berg et al., 1995; van der Poll et 
al., 1997; Walley et al., 1996). Lipopolysaccharides (LPS) are well-known bacterial toxins and 
potent inducers of inflammatory responses. It has been suggested that epithelial cells are 
refractory to LPS since they do not express surface CD14, an important signaling protein 
that functions by docking the LPS/LBP (Lipid binding protein)- complex with TLR4 to 
initiate intracellular signaling cascades (Svanborg et al., 1999). However, in the presence of 
serum cells, epithelial cells respond to LPS, demonstrating the presence of a second soluble 
form of CD14 (sCD14) (Noel et al., 1995; Riedel et al., 2006). Furthermore, CD14- 
independent pathways are also present in epithelial cells that can be triggered by substances 
such as peptidoglycan and result in the release of pro-inflammatory cytokines (Sato et al., 
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2003).  While inflammatory responses are mainly induced through signals transduced via 
TLRs on epithelial cell surface, there is evidence indicating involvement of other membrane 




Fig. 1. Inflammation induced by LPS, which binds to TLR4 and signals for MyD88 activation 
that in turn starts a phosphorylation cascade leading to NF-κB activation and nuclear 
translocation. 
1.4 NF-B and MAPK signaling pathways  
Recognition of toxins by epithelial- and immune cells occurs via TLRs that activate specific 
intracellular signaling pathways and result in the transcription of essential proteins for 
survival. Currently, more than 10 TLRs have been identified and recognize; among others, 
zymosan (TLR1/TLR2), LPS-LTA (TLR4-TLR2/TLR6) and dsRNA (TLR3) (Xu et al., 2001). 
NF-B has a central role in the induction of inflammatory responses by regulating a wide 
range of genes. Several stress factors can activate NF-B, including bacterial toxins, 
cytokines, reactive oxygen species and UV light. Bacterial toxins, such as LPS and 
peptidoglycan, activate NF-B via TLRs whereas cytokines, TNF, IL-1, signal via TNF-R1 
and IL-1R on the membrane surface (Dinarello, 2000). LPS activates NF-B following 
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binding to a LPS-binding protein, which facilitates LPS binding to CD14. Once bound to 
CD14, the LPS-binding protein dissociates, and the LPS-CD14 complex associates with TLR4 
with the help of the extracellular protein MD2. The binding of LPS-CD14 complex leads to 
the activation and binding of a cytoplasmic signaling molecule called myeloid 
differentiation factor 88 (MyD88). Binding of MyD88 leads to the activation of interleukin-1-
receptor-associated kinase (IRAK), which phosphorylates TNF-receptor-associated factor 
(TRAF) 6. TRAF6 leads to the activation of TGF-beta activated kinase (TAK) 1, which 
activates NF-κB-inducible kinase (NIK). IκB kinase (IKK), activated by NIK, phosphorylates 
the inhibitory protein IB followed by subsequent degradation in the proteasome. This leads 
to NF-B activation, which translocates into the nucleus and initiates transcription of a wide 
range of inflammatory genes (Fig. 1) (Ali & Mann, 2004). 
An additional important signaling pathway involved in the induction of cytokines and 
inflammation is the mitogen-activated protein kinase (MAPK) pathway. Several stress 
factors can induce the activation of MAPK pathway, however only pro-inflammatory 
cytokines and growth factors can induce inflammation, apoptosis or differentiation through 
either p38 MAPK or c-Jun NH2-terminal kinase (JNK). There are three major groups of 
MAPKs; p38 Map kinase family, extracellular signal-regulated kinase (Erk) family and JNK 
family (McCarroll et al., 2003). A series of phosphorylation steps are the key events leading 
to MAPK activation and gene-expression (Faure et al., 1994). Furthermore, activation of the 
Raf/MAPK pathway has been shown to stimulate transcription of, among others, cytokines 
through AP-1, NF-IL6 and NF-B (Bruder & Kovesdi, 1997). 
Since T-cells lack TLRs, antigens are recognized by the TCR with the help of co-stimulatory 
receptors, such as CD28. This results in the activation of resting T-cells and a signaling 
cascade that activates phospholipase C (PLC) and cleavage of phosphatidylinositol bis-
phosphate (PIP2) to inositol (1,4,5)-trisphosphate (IP3) and diacylglycerol (DAG) (Teixeira et 
al., 2003). IP3 mobilize Ca2+ from intracellular stores and together with DAG activates PKC 
(Gajewski et al., 1994; Werlen et al., 1998). In addition, Ca2+ also activates 
calcineurin/calmodulin and RasGRP, which is a Ras activator and is directly connected to 
the MAPK pathway (Dower et al., 2000). Recent reports have revealed the importance of 
three additional intracellular proteins, namely CARMA1, Bcl10 and MALT1 (CBM) in the 
induction of NF-B (Scharschmidt et al., 2004). Down regulation of Bcl10 was shown to 
result in inhibition of NF-B, transduced via TCR/CD28 and PKC. It was suggested that 
Bcl10 is initially activated by TCR/PKC but further activation (>1h) promotes its 
degradation. Furthermore, deletion of any component of the CBM complex impairs antigen 
receptor activation of NF-B (Gaide et al., 2002; Narayan et al., 2006). CARMA1 has been 
shown to be required for NF-B activation through Akt signaling, in cooperation with PKC 
following short-term exposure (30min) of Jurkat T-cells with PMA (Narayan et al., 2006). 
These studies indicate that PKC is crucial for NF-B activation, following short-term 
exposure; from signals transduced via TCR and co-stimulatory receptors, such as CD28, and 
that the CBM complex proteins play a key role in these signaling processes (Fig. 2).  
NF-κB is an important transcription factor complex involved in almost every aspect of cell 
regulation including apoptosis, differentiation, proliferation and initiation of immune 
responses (Barnes & Adcock, 1997; Makarov, 2000; Tergaonkar, 2006). NF-κB is an attractive 
therapeutic target since it is constitutively active in many human malignancies (Dolcet et al., 
2005).  
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Fig. 2. T-cells recognize antigens via TCR and co-stimulatory receptors (CD28), leading to a 
downstream signaling cascade involving PKC activation and several transcription factors 
including NF-B, AP-1 and NFAT. 
2. CXCL8 regulation and signal transduction 
In order to understand how CXCL8 contributes to the etiology of HIV, it is important to 
characterize the cellular signal transduction pathways regulating CXCL8. There are over 50 
chemokines identified and almost 18 chemokine receptors have been characterized (Alfano 
& Poli, 2005). Chemokines are divided into four categories according to the location of two 
cysteine residues at the N-terminal region. These include C, CC, CXC and CX3C chemokines 
(Zlotnik & Yoshie, 2000). Chemokine receptors have been designated the same 
nomenclature as for their respective chemokine. Besides several immune cells, many other 
cell types have been described to express chemokine receptors, including endothelial cells, 
fibroblasts and smooth muscle cells (Garcia-Vicuna et al., 2004). This indicates that 
chemokines are not only implicated in the regulation of cell trafficking but also in cell 
proliferation and gene regulation (Wong & Fish, 2003).  
Several chemokines share the same receptor but possess different binding affinities to each 
one. We have previously shown an association between IL-6 release and NF-B activity 
while CXCL8 release was more closely correlated with activator protein (AP)-1 activity 
(Khalaf et al., 2010). Blocking NF-B activation resulted in a complete inhibition of IL-6 
while the CXCL8 levels remained elevated as shown both at the protein and mRNA levels. 
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Our results indicate that in Jurkat T-cells, IL-6 is regulated through NF-B while CXCL8 
regulation is independent of NF-B and is closely associated with AP-1 activation. The 
interplay between immune cells and the expression levels of different 
cytokines/chemokines is an important factor for consideration.  
The gram-negative derived endotoxin, LPS, is a known factor reported to induce CXCL8 
expression and release. However, pre-treatment with anti-inflammatory cytokines, 
including IL-4, IL-10 and TGF-1, resulted in a significant reduction in CXCL8 expression 
(Ehrlich et al., 1998). Thus, the balance between pro- and anti-inflammatory cytokines is a 
determinant factor for immune cell activation as well as the expression levels of cytokines 
and chemokines released by different cells. Maintaining this balance is therefore of great 
importance, however there is a need to improve our understanding about the regulatory 
mechanisms controlling the expression of inflammatory mediators and their effect(s) on 
different immune cells.  
The main regulators of cxcl8 gene expression are NF-B and the MAP kinases JNK, ERK and 
p38 leading to the assembly and activation of the transcription factor AP-1. NF-B is 
required for CXCL8 release in most cell types, while optimal induction is achieved following 
binding of additional transcription factor including MAP kinases and C/EBP (Hoffmann et 
al., 2002). However, the ratio of activation between NF-B to MAPK and other transcription 
factors in this regulatory mechanism seems to differ depending on the pressure caused by a 
specific stress factor and cell type. In airway epithelial cells NF-B, ERK and JNK were 
found to be essential for TNF-induced CXCL8 expression, while p38 acted as a 
posttranscriptional regulator (Li et al., 2002). Even though p38 is not required for cxcl8 gene 
expression, it plays a major role in CXCL8 release by stabilizing its mRNA through protein 
kinase-2 (Hoffmann et al., 2002). A simplified representation of the signaling pathways 
involved in CXCL8 expression and regulation is shown in figure 3. Furthermore, reactive 
oxygen intermediates (ROI) are important regulators of cytokine and chemokine expression 
and has been shown to mediate a dose-dependent CXCL8 expression (DeForge et al., 1993). 
They further demonstrated that the effect of these potent immune regulators could be 
almost completely abolished by applying the OH-radical scavenger DMSO, which reduced 
CXCL8 expression by 90%.  
There are two well-characterized receptors for CXCL8, namely CXC chemokine receptor 
(CXCR)-1 and -2. CXCL8 binds to these receptors with high affinity (Bertini et al., 2004), 
while CXCR1 is specific for CXCL8, (NAP)-2 and granulocyte chemotactic protein (GCP)-2, 
CXCR2 can bind additional chemokines, including CXCL1, 2, 3, 5, 6 and 7 (Acosta et al., 
2008). Despite their structural similarities, these receptors possess different biological effects 
through distinct signaling pathways (Gabellini et al., 2009). 
Signals transduced through CXCR1 stimulate neutrophil migration through epithelial 
layers, while CXCR2 signaling promotes angiogenesis (Sturm et al., 2005). The intracellular 
protein Bcl-10 has been proposed to play a critical role in the signaling pathway leading to 
CXCL8 expression and its enhancement of angiogenesis through CXCR2 (Karl et al., 2005). 
Both NF-B and C/EBP have been reported to be downstream targets of activation in the 
CXCR2 signaling cascade, ultimately leading to CXCL8 expression, creating a positive 
feedback loop (Acosta & Gil, 2009). This positive feedback loop leading to neutrophil 
activation and migration is regulated by internalization of CXCR1 and CXCR2 upon ligand 
binding. Furthermore, a second regulatory mechanism of CXCL8 receptor expression 
involves metalloproteinases as important regulatory factors (Khandaker et al., 1999). They 
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demonstrated a significant reduction of CXCR1 and CXCR2 following exposure of 
neutrophils with LPS or TNF that was shown to act through activation of serine proteinases. 
This may indicate that a mechanism used by microorganisms to evade the immune system 
is by reducing neutrophil migration towards the infected site. CXCR1 was further shown to 
be expressed on cytotoxic CD8+ effector T-cells, indicating the vital physiological role of 
CXCL8 in recruiting lymphocytes and therefore acting as an important link between innate 
and adaptive immunity (Takata et al., 2004).  
 
 
Fig. 3. Intracellular signaling cascade leading to cxcl8 gene expression. NF-B (p50, p65) and 
AP-1 (jun, fos) are the main regulators at the transcriptional level, while p38 serves to 
stabilize the mRNA molecules.  
3. Targeting CXCL8 in HIV treatment strategies 
CXCL8 has been implicated in many cellular responses, such as HIV pathogenesis, 
angiogenesis and cell growth and survival. HIV-infected individuals have elevated CXCL8 
levels that, due to the potent chemo-attractant characteristics of CXCL8, can result in the 
recruitment of target cells, leading to a progressive infection and HIV-1 replication (Ott et 
al., 1998). However, it has also been suggested that CXCL8 is involved in decreased 
replication of HIV-1 during the early stages of infection (Rollenhagen & Asin, 2010). In 
addition, CXCL8 can act as a potent anti-apoptotic agent, inducing the expression of pro-
survival proteins, including Bcl-2 and Bcl-xL (Li et al., 2003). While the role of CXCL8 
remains complex it remains an interesting candidate as a suitable therapeutic target in HIV 
treatment.  
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Cellular HIV infection involves interactions between glycoprotein gp120, CD4 and CC/CXC 
receptors (Suresh & Wanchu, 2006). It is therefore possible that an HIV infection can be 
interrupted and the progression of an established infection can be delayed by targeting CC 
and/or CXC chemokine receptors. There are two well characterized chemokine receptors by 
which HIV can bind, enter and infect monocytes, microglia and T-lymphocytes, namely 
CCR5 and CXCR4 (Ghafouri et al., 2006). CXCL8 dependent activation of CXCR1 has also 
been suggested to result in inhibited HIV infection and entry into cells (Richardson et al., 
2003). Richardson and colleagues showed that CXCR1 activation and internalization 
resulted in a cross-phosphorylation and internalization of CCR5. Furthermore, C-terminal 
mutation of CXCR1 internalized both CCR5 and CXCR4 and thus inhibited HIV-1 infection 
and entry. Furthermore, since HIV-1 competes with CCL5 and CXCL8 for the chemokine 
receptor DARC (duffy antigen receptor for chemokines) the serum levels of these 
chemokines may affect the progression of HIV by binding to their respective receptors (He 
et al., 2008). HIV-1 binding to DARC was also shown to affect chemokine-induced 
inflammation.  
Even though CXCL8 expression is impaired in HIV-infected cells, pro-inflammatory 
cytokines such as TNF can induce CXCL8 production and expression from other immune 
cells. It was recently demonstrated that HIV-infected macrophages secrete TNF and IL-1 
that in turn act on astrocytes to induce CXCL8 production (Zheng et al., 2008). CXCL8 
production was mediated through the MAPK-associated pathways, including p38, c-Jun N-
terminal kinase (JNK) and extracellular signal-regulated kinases (ERK1/2). This 
inflammatory process plays an important role in the pathogenesis of HIV-associated 
dementia. Reduction of CXCL8 production can therefore be used to control immune cell 
migration into the central nervous system, which will reduce the overall inflammatory 
responses at this site. In addition, CXCL8 is co-localize with CD68/CD40 cells, and CD40 
receptor expression on microglial cells act as potent inducers of CXCL8 expression, through 
AP-1 and NF-B, following ligation of its ligand CD40L, which is expressed on monocytes 
and T-lymphocytes (D'Aversa et al., 2008). Taken together, these studies show the 
importance of understanding the regulatory mechanisms leading to chemokine expression 
in T-cells and other immune cells in order to find a suitable target to control HIV replication 
and progression.  
Antiretroviral drugs that target different structural properties in HIV have failed to 
eradicate the virus but rather suppressed its spreading and pathogenesis. These difficulties 
have been due to the variability and ability of HIV to internalize without being detected, 
followed by reactivation (Archer et al., 2009). These drugs are therefore applied in a 
combination to inhibit several steps of the viral life cycle, including proteases to inhibit 
maturation, reverse transcription inhibitors and inhibitors for HIV integration into the 
genome (Arhel & Kirchhoff, 2010). Other difficulties include drug-drug interactions and 
long-term toxicities (Tilton & Doms, 2010). However, as chemokine levels are severely 
altered in HIV infected individuals and are involved in HIV replication this has led to an 
interest in applying this knowledge to controling HIV infections (Llano & Esté, 2005). 
Alternative treatment methods have been developed, targeting host proteins/receptors that 
are used by the virus to enter and infect a cell, such as maraviroc, which is a CCR5 
antagonist (Swenson et al., 2011). As viruses are divided into CCR5- and CXCR4-dependent 
(Pilcher et al., 2004), it is important to accurately determine this mechanism before applying 
a specific treatment to successfully reduce/inhibit HIV spread and pathogenesis. However, 
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although an initial virus infection is CCR5-dependent, a large subset will switch to using 
CXCR4 as a co-receptor. This is a major concern since maraviroc has little or no effect on 
CXCR4-dependent viruses (Kuritzkes, 2011). The interplay between different immune cells 
during an established HIV infection remains important to understand. Determination of 
cytokine expression by specific cells and the effect that these inflammatory mediators have 
on other cells to produce chemokines is also important. Further investigations are needed to 
evaluate the patterns of immune cell activation and cytokine/chemokine regulation in order 
to find suitable therapeutic targets.  
4. Probiotic Lactobacillus as an alternative HIV treatment strategy 
Lactobacillus spp are part of the healthy human microbiota, found primarily in the 
gastrointestinal and vaginal tracts. Certain Lactobacillus spp have been identified as health 
promoting probiotic bacteria by inhibiting pathogen colonization and modulating the 
immune response in the host (reviewed in Reid et al., 2003). Evidence of immune 
modulating properties exhibited by certain lactobacilli strains has been shown through their 
ability to alter cytokine expression in tissue cells infected by pathogens, in vitro and in vivo, 
and thus helping maintain homeostasis (Anukam et al., 2009; Frick et al., 2007; Moorthy et 
al., 2010; Nandakumar et al., 2009; van Hemert et al., 2010; Zhang et al., 2005). Altered 
cytokine responses, including TNF, NF-B, IL-6, IL-1, CXCL8, IL-10 and IL-12, are 
dependent on cell type (human mucosal epithelial cells, human mononuclear cells, T-cells, 
dendritic cells etc) and Lactobacillus species and strain (Nandakumar et al., 2009; van Hemert 
et al., 2010). From these reports, probiotic lactobacilli demonstrate a clear potential for both 
development of new strategies to reduce the risk of HIV infection and combat AIDS 
progression through their anti-infective and immune-modulating properties. 
Vaginal infections such as bacterial vaginosis (BV) and candidiasis have been correlated 
with an increased risk of HIV infection (Sha et al., 2005; St John et al., 2007). BV and 
candidiasis are characterized by microbiota that is comprised of a range of anaerobic 
bacteria or Candida albicans, respectively, while deficient in lactobacilli (Sha et al., 2005). 
Furthermore, women already infected with HIV that lacked vaginal lactobacilli and had BV 
or candidiasis had higher levels of HIV shedding in the genital tract (Coleman et al., 2007; 
Spinillo et al., 2005). Increased HIV transcripts in vaginal cells and viral shedding increases 
the risk of HIV transmission. Furthermore, vaginal secretions from women with BV 
increased HIV expression in chronically infected monocyte cell line in vitro, while secretions 
from women without BV had no effect on HIV expression (Spear et al., 2007). This is 
believed to be due to the higher levels of proinflammatory cytokines primarily those that 
function through NF-B (Al-Harthi et al., 1998). C. albicans infections increase vaginal 
CXCL8 levels and neutrophil presence while higher levels of vaginal lactobacilli reduced 
CXCL8 levels and other pro-inflammatory cytokines (Spear et al., 2008). CXCL8 is a potent 
chemokine that recruits neutrophils to the site of infections, thus by reducing chemokine 
levels, the target cells for HIV infection are limited. Using lactobacilli to modulate the 
CXCL8 levels and other pro-inflammatory signals may thus reduce the risk of HIV infection 
and reduce viral replication.  
Certain Lactobacillus spp have been shown to reduce pro-inflammatory cytokine release from 
stimulated cells. The probiotic Lactobacillus rhamnosus GG reduced the cxcl8 expression and 
CXCL8 and CCL11 secretion in TNF or IL-1 - stimulated human intestinal epithelial cells 
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(Caco-2bbe) by blocking NF-B activation and nuclear translocation (Donato et al., 2010). In 
the same study, related bacteria Lactobacillus farciminis and Lactobacillus plantarum RO403 did 
not alter the CXCL8 or CCL11 levels in the stimulated cells. Others reported that L. 
plantarum 299v showed differential influence on expression and secretion of CXCL8 in HT-
29 colonic epithelial cells that were treated with TNF. L. plantarum 299v enhanced the cxcl8 
mRNA above that of TNF treatment alone while decreasing CXCL8 secretion from HT-29 
cells (McCracken et al., 2002). The L. plantarum 299v alone did not induce CXCL8. This is 
especially interesting since CXCL8 has been shown to decreases transcription of RS-Tropic 
HIV-1 in peripheral blood lymphocytes and decreases replication in ectocervical tissue 
explants (Rollenhagen & Asin, 2010; Tiemessen et al., 2000). However, another study had 
reported that increased levels of CXCL8 stimulated HIV-1 replication in T lymphocytes and 
macrophages, and this could be significantly inhibited using CXCL8 antibodies or blocking 
CXCR1 and CXCR2 receptors (Lane et al., 2001).  High levels of secreted CXCL8 have been 
associated with chronic infections in HIV infected persons, thus recruiting and exposing the 
target cells for HIV infection. Modulation of CXCL8 suggests a potential role for certain 
strains of lactobacilli in reducing the risk for HIV infection and disease progression.   
5. Genetically modified lactobacilli for HIV treatment  
Commensal Lactobacillus spp from the gastrointestinal and vaginal tract have been 
considered safe and thus have been used to develop genetically engineered lactobacilli as 
potential live antiviral-fusion delivery systems. Several investigators have genetically 
engineered a human isolate of Lactobacillus jensenii to secrete fusion inhibitors that target 
necessary receptors for HIV infection with the aim of being used as a vaginal topical 
treatment. Chang and colleagues have genetically engineered L. jensenii to produce a two-
domain CD4 protein that bound the HIV-1 gp120 moderately inhibiting HIV binding and 
entry into Hela cells expressing CD4-CXCR4 in vitro (Chang et al., 2003). Similarly, other 
fusion inhibitors have been successfully expressed from L. jensenii such as the anti-HIV-1 
chemokine RANTES and a mutated CCR5 antagonist that showed inhibition of infecting T-
cells and macrophages in a concentration dependent manner (Vangelista et al., 2010). A 
recent patent has been filed for genetically engineered L. reuteri RC-14 to be used in 
treatment of HIV and AIDS after infection by secreting fusion inhibitors in the 
gastrointestinal tract to reduce or slow the progression of AIDS (Lemke 2010; Patent #US 
2010/0143305 A1). One report showed that L. rhamnosus GR-1 and L reuteri RC-14 did not 
naturally have the ability to alter RANTES in yeast-infected epithelial cells and L. rhamnosus 
GG did not induce the expression of CCL5 (Martinez et al., 2009; Nandakumar et al., 2009). 
However, to the authors’ knowledge, there has been no systematic evaluation of lactobacilli 
for inducing HIV-1 fusion inhibitors in cell. The combination of genetically engineered 
lactobacilli strains to express fusion inhibitor molecules, including CXCR1 and 2 and CXCL8 
modulation may further reduce HIV infection and AIDS progression.  
6. Conclusions 
It is clear that cytokines and chemokines are important factors in HIV infection and disease 
progression, making them plausible targets for anti-HIV therapy and to slow the 
progression to AIDS. CXCL8 is an important factor to consider in HIV therapy, as it is 
responsible for the recruitment of neutorphils and T-cells to the site of infection. As HIV 
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targets immune cells and thereby interferes with the innate immune systems, it is of interest 
to develop methods to block or reduce the ability of HIV to infect immune cells. Therefore, 
in order to develop viable CXCL8 based treatment strategies it is important to identify the 
signaling pathways involved in CXCL8 regulation as well as to determine the function of 
CXCL8 and its receptors in different physiological responses. 
Certain lactobacilli have been shown to have immune modulating abilities. There is a clear 
potential for using probiotic lactobacilli to counter infections, including HIV, as they have 
both anti-infective and immune-modulating properties. From this aspect, the ideal probiotic 
Lactobacillus species/strain for therapeutic use is one that increases intracellular CXCL8, 
while maintains a low level of secreted pro-inflammatory cytokines, such as NF-kB, TNF, 
CXCL8 and IL-6, that promote HIV replication and recruit HIV-target cells. Combining the 
health promoting properties of lactobacilli with modulation of cxcl8 expression and release 
can be of great importance in fighting HIV infections. 
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The continuing AIDS pandemic reminds us that despite the unrelenting quest for knowledge since the early
1980s, we have much to learn about HIV and AIDS. This terrible syndrome represents one of the greatest
challenges for science and medicine. The purpose of this book is to aid clinicians, provide a source of
inspiration for researchers, and serve as a guide for graduate students in their continued search for a cure of
HIV. The first part of this book, â€œFrom the laboratory to the clinic,â€ ​ and the second part, â€œFrom the
clinic to the patients,â€ ​ represent the unique but intertwined mission of this work: to provide basic and clinical
knowledge on HIV/AIDS.
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